Vistin Pharma ASA (FRA:VP4)

Vistin Pharma ASA Statistics

Total Valuation

FRA:VP4 has a market cap or net worth of EUR 84.16 million. The enterprise value is 82.75 million.

Market Cap	84.16M
Enterprise Value	82.75M

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	Jun 4, 2025

Share Statistics

Current Share Class	44.34M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	38.85%
Owned by Institutions (%)	23.39%
Float	20.96M

Valuation Ratios

The trailing PE ratio is 13.32.

PE Ratio	13.32
Forward PE	n/a
PS Ratio	2.20
PB Ratio	3.03
P/TBV Ratio	3.03
P/FCF Ratio	16.06
P/OCF Ratio	12.66
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.08, with an EV/FCF ratio of 15.79.

EV / Earnings	13.10
EV / Sales	2.05
EV / EBITDA	8.08
EV / EBIT	10.06
EV / FCF	15.79

Financial Position

The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.00.

Current Ratio	2.58
Quick Ratio	1.54
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.02
Interest Coverage	8.38

Financial Efficiency

Return on equity (ROE) is 23.42% and return on invested capital (ROIC) is 22.30%.

Return on Equity (ROE)	23.42%
Return on Assets (ROA)	14.00%
Return on Invested Capital (ROIC)	22.30%
Return on Capital Employed (ROCE)	25.62%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	523,470
Profits Per Employee	86,519
Employee Count	73
Asset Turnover	1.10
Inventory Turnover	1.91

Taxes

In the past 12 months, FRA:VP4 has paid 1.78 million in taxes.

Income Tax	1.78M
Effective Tax Rate	22.00%

Stock Price Statistics

The stock price has decreased by -8.56% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.56%
50-Day Moving Average	1.82
200-Day Moving Average	n/a
Relative Strength Index (RSI)	51.15
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:VP4 had revenue of EUR 38.21 million and earned 6.32 million in profits. Earnings per share was 0.14.

Revenue	38.21M
Gross Profit	25.41M
Operating Income	7.80M
Pretax Income	8.10M
Net Income	6.32M
EBITDA	9.71M
EBIT	7.80M
Earnings Per Share (EPS)	0.14

Balance Sheet

The company has 1.39 million in cash and 126,732 in debt, with a net cash position of 1.26 million.

Cash & Cash Equivalents	1.39M
Total Debt	126,732
Net Cash	1.26M
Net Cash Per Share	n/a
Equity (Book Value)	27.78M
Book Value Per Share	0.63
Working Capital	10.52M

Cash Flow

In the last 12 months, operating cash flow was 6.65 million and capital expenditures -1.41 million, giving a free cash flow of 5.24 million.

Operating Cash Flow	6.65M
Capital Expenditures	-1.41M
Free Cash Flow	5.24M
FCF Per Share	n/a

Margins

Gross margin is 66.50%, with operating and profit margins of 20.42% and 16.53%.

Gross Margin	66.50%
Operating Margin	20.42%
Pretax Margin	21.19%
Profit Margin	16.53%
EBITDA Margin	25.40%
EBIT Margin	20.42%
FCF Margin	13.71%

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 5.97%.

Dividend Per Share	0.11
Dividend Yield	5.97%
Dividend Growth (YoY)	37.64%
Years of Dividend Growth	n/a
Payout Ratio	74.15%
Buyback Yield	n/a
Shareholder Yield	5.97%
Earnings Yield	7.50%
FCF Yield	6.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:VP4 has an Altman Z-Score of 8.35 and a Piotroski F-Score of 7.

Altman Z-Score	8.35
Piotroski F-Score	7